B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

NCT05474378 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Brain and Nervous System

Interventions

DRUG: B7-H3CART

Sponsor

Stanford University

Collaborators

[object Object]
[object Object]